PSTI Annual Total Long Term Liabilities
$29.05 M
+$4.18 M+16.81%
01 June 2022
Summary:
As of January 21, 2025, PSTI annual total long term liabilities is $29.05 million, with the most recent change of +$4.18 million (+16.81%) on June 1, 2022. During the last 3 years, it has risen by +$27.72 million (+2082.57%).PSTI Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI Quarterly Long Term Liabilities
$27.84 M
-$1.22 M-4.18%
01 September 2022
Summary:
As of January 21, 2025, PSTI quarterly total long term liabilities is $27.84 million, with the most recent change of -$1.22 million (-4.18%) on September 1, 2022. Over the past year, it has increased by +$3.36 million (+13.73%).PSTI Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI Long Term Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +16.8% | +13.7% |
| 3 y3 years | +2082.6% | +1163.5% |
| 5 y5 years | +1454.3% | +1430.2% |
PSTI Long Term Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | at high | -12.3% |
Pluristem Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $27.84 M(-4.2%) |
| June 2022 | $29.05 M(+16.8%) | $29.05 M(-6.8%) |
| Mar 2022 | - | $31.16 M(-1.8%) |
| Dec 2021 | - | $31.75 M(+29.7%) |
| Sept 2021 | - | $24.48 M(-1.6%) |
| June 2021 | $24.87 M(+1622.3%) | $24.87 M(+2116.6%) |
| Mar 2021 | - | $1.12 M(+0.3%) |
| Dec 2020 | - | $1.12 M(-32.5%) |
| Sept 2020 | - | $1.66 M(+14.8%) |
| June 2020 | $1.44 M(+8.5%) | $1.44 M(-12.5%) |
| Mar 2020 | - | $1.65 M(-15.7%) |
| Dec 2019 | - | $1.96 M(-11.1%) |
| Sept 2019 | - | $2.20 M(+65.5%) |
| June 2019 | $1.33 M(-30.1%) | $1.33 M(-28.3%) |
| Mar 2019 | - | $1.86 M(-1.0%) |
| Dec 2018 | - | $1.88 M(-4.6%) |
| Sept 2018 | - | $1.97 M(+3.2%) |
| June 2018 | $1.91 M(+1.9%) | $1.91 M(-1.6%) |
| Mar 2018 | - | $1.94 M(-2.0%) |
| Dec 2017 | - | $1.98 M(+8.6%) |
| Sept 2017 | - | $1.82 M(-2.7%) |
| June 2017 | $1.87 M(-7.0%) | $1.87 M(+4.6%) |
| Mar 2017 | - | $1.79 M(-1.2%) |
| Dec 2016 | - | $1.81 M(-6.4%) |
| Sept 2016 | - | $1.93 M(-3.9%) |
| June 2016 | $2.01 M(-47.5%) | $2.01 M(-2.9%) |
| Mar 2016 | - | $2.07 M(-0.4%) |
| Dec 2015 | - | $2.08 M(-44.1%) |
| Sept 2015 | - | $3.72 M(-2.8%) |
| June 2015 | $3.83 M(-15.0%) | $3.83 M(-1.0%) |
| Mar 2015 | - | $3.87 M(-4.0%) |
| Dec 2014 | - | $4.03 M(-2.9%) |
| Sept 2014 | - | $4.15 M(-7.8%) |
| June 2014 | $4.50 M(-8.6%) | $4.50 M(-9.7%) |
| Mar 2014 | - | $4.99 M(+1.5%) |
| Dec 2013 | - | $4.92 M(-0.9%) |
| Sept 2013 | - | $4.96 M(+0.6%) |
| June 2013 | $4.93 M | $4.93 M(+8.3%) |
| Mar 2013 | - | $4.55 M(+15.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2012 | - | $3.95 M(-1.7%) |
| Sept 2012 | - | $4.02 M(-3.3%) |
| June 2012 | $4.16 M(+621.5%) | $4.16 M(+0.4%) |
| Mar 2012 | - | $4.14 M(-4.0%) |
| Dec 2011 | - | $4.31 M(-4.2%) |
| Sept 2011 | - | $4.50 M(+682.1%) |
| June 2011 | $576.00 K(+60.0%) | $576.00 K(+14.5%) |
| Mar 2011 | - | $503.00 K(+19.8%) |
| Dec 2010 | - | $420.00 K(+4.2%) |
| Sept 2010 | - | $403.00 K(+11.9%) |
| June 2010 | $360.00 K(+57.2%) | $360.00 K(+8.4%) |
| Mar 2010 | - | $332.00 K(+15.3%) |
| Dec 2009 | - | $288.00 K(+16.1%) |
| Sept 2009 | - | $248.00 K(+8.3%) |
| June 2009 | $229.00 K(+25.1%) | $229.00 K(+18.7%) |
| Mar 2009 | - | $193.00 K(-4.5%) |
| Dec 2008 | - | $202.00 K(+3.1%) |
| Sept 2008 | - | $196.00 K(+7.1%) |
| June 2008 | $183.00 K(+88.9%) | $183.00 K(+10.2%) |
| Mar 2008 | - | $166.00 K(-8.8%) |
| Dec 2007 | - | $182.00 K(+16.7%) |
| Sept 2007 | - | $156.00 K(+61.0%) |
| June 2007 | $96.90 K(-97.1%) | $96.90 K(+2.2%) |
| Mar 2007 | - | $94.80 K(+24.4%) |
| Dec 2006 | - | $76.20 K(-97.0%) |
| Sept 2006 | - | $2.54 M(-23.8%) |
| June 2006 | $3.33 M(+811.3%) | $3.33 M(+5466.9%) |
| Mar 2006 | - | $59.90 K(+15.4%) |
| Dec 2005 | - | $51.90 K(-79.8%) |
| Sept 2005 | - | $257.10 K(-29.7%) |
| June 2005 | $365.90 K(-41.8%) | $365.90 K(-77.9%) |
| Mar 2005 | - | $1.65 M(+366.8%) |
| Dec 2004 | - | $354.10 K(-14.9%) |
| Sept 2004 | - | $416.10 K(-33.8%) |
| June 2004 | $628.60 K(+153.3%) | $628.60 K(-55.9%) |
| Mar 2004 | - | $1.43 M(+676.3%) |
| Dec 2003 | - | $183.60 K(-27.3%) |
| Sept 2003 | - | $252.40 K(+1.7%) |
| June 2003 | $248.20 K | $248.20 K |
FAQ
- What is Pluristem Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Pluristem Therapeutics?
- What is Pluristem Therapeutics annual total long term liabilities year-on-year change?
- What is Pluristem Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Pluristem Therapeutics?
- What is Pluristem Therapeutics quarterly long term liabilities year-on-year change?
What is Pluristem Therapeutics annual total long term liabilities?
The current annual total long term liabilities of PSTI is $29.05 M
What is the all time high annual total long term liabilities for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual total long term liabilities is $29.05 M
What is Pluristem Therapeutics annual total long term liabilities year-on-year change?
Over the past year, PSTI annual total long term liabilities has changed by +$4.18 M (+16.81%)
What is Pluristem Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of PSTI is $27.84 M
What is the all time high quarterly long term liabilities for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly total long term liabilities is $31.75 M
What is Pluristem Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, PSTI quarterly total long term liabilities has changed by +$3.36 M (+13.73%)